A citation-based method for searching scientific literature

Richard T Kloos, Charis Eng, Douglas B Evans, Gary L Francis, Robert F Gagel, Hossein Gharib, Jeffrey F Moley, Furio Pacini, Matthew D Ringel, Martin Schlumberger, Samuel A Wells. Thyroid 2009
Times Cited: 782







List of co-cited articles
723 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
733
63

Guidelines for diagnosis and therapy of MEN type 1 and type 2.
M L Brandi, R F Gagel, A Angeli, J P Bilezikian, P Beck-Peccoz, C Bordi, B Conte-Devolx, A Falchetti, R G Gheri, A Libroia,[...]. J Clin Endocrinol Metab 2001
21

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.
L M Mulligan, J B Kwok, C S Healey, M J Elsdon, C Eng, E Gardner, D R Love, S E Mole, J K Moore, L Papi. Nature 1993
20

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.
C Eng, D Clayton, I Schuffenecker, G Lenoir, G Cote, R F Gagel, H K van Amstel, C J Lips, I Nishisho, S I Takai,[...]. JAMA 1996
768
19

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
H Donis-Keller, S Dou, D Chi, K M Carlson, K Toshima, T C Lairmore, J R Howe, J F Moley, P Goodfellow, S A Wells. Hum Mol Genet 1993
16

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli,[...]. J Clin Oncol 2012
746
16

Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.
Samuel A Wells, Furio Pacini, Bruce G Robinson, Massimo Santoro. J Clin Endocrinol Metab 2013
154
16


Cabozantinib in progressive medullary thyroid cancer.
Rossella Elisei, Martin J Schlumberger, Stefan P Müller, Patrick Schöffski, Marcia S Brose, Manisha H Shah, Lisa Licitra, Barbara Jarzab, Viktor Medvedev, Michael C Kreissl,[...]. J Clin Oncol 2013
552
13

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
12

Medullary thyroid carcinoma.
Sophie Leboulleux, Eric Baudin, Jean-Paul Travagli, Martin Schlumberger. Clin Endocrinol (Oxf) 2004
211
12

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.
Rossella Elisei, Barbara Cosci, Cristina Romei, Valeria Bottici, Giulia Renzini, Eleonora Molinaro, Laura Agate, Agnese Vivaldi, Pinuccia Faviana, Fulvio Basolo,[...]. J Clin Endocrinol Metab 2008
294
11

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.
L M Mulligan, C Eng, C S Healey, D Clayton, J B Kwok, E Gardner, M A Ponder, A Frilling, C E Jackson, H Lehnert. Nat Genet 1994
541
11

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes.
Cristina Romei, Stefano Mariotti, Laura Fugazzola, Augusto Taccaliti, Furio Pacini, Giuseppe Opocher, Caterina Mian, Maurizio Castellano, Ettore degli Uberti, Isabella Ceccherini,[...]. Eur J Endocrinol 2010
86
11

Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS.
Nishant Agrawal, Yuchen Jiao, Mark Sausen, Rebecca Leary, Chetan Bettegowda, Nicholas J Roberts, Sheetal Bhan, Allen S Ho, Zubair Khan, Justin Bishop,[...]. J Clin Endocrinol Metab 2013
121
10

Early malignant progression of hereditary medullary thyroid cancer.
Andreas Machens, Patricia Niccoli-Sire, Josef Hoegel, Karin Frank-Raue, Theo J van Vroonhoven, Hans-Dietrich Roeher, Robert A Wahl, Peter Lamesch, Friedhelm Raue, Bernard Conte-Devolx,[...]. N Engl J Med 2003
326
10

The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.
Rossella Elisei, Cristina Romei, Giulia Renzini, Valeria Bottici, Barbara Cosci, Eleonora Molinaro, Laura Agate, Virginia Cappagli, Paolo Miccoli, Piero Berti,[...]. J Clin Endocrinol Metab 2012
64
15

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
R M Hofstra, R M Landsvater, I Ceccherini, R P Stulp, T Stelwagen, Y Luo, B Pasini, J W Höppener, H K van Amstel, G Romeo. Nature 1994
925
9


Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10.
Karin Frank-Raue, Lisa A Rybicki, Zoran Erlic, Heiko Schweizer, Aurelia Winter, Ioana Milos, Sergio P A Toledo, Rodrigo A Toledo, Marcos R Tavares, Maria Alevizaki,[...]. Hum Mutat 2011
79
11

In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer.
B Cosci, A Vivaldi, C Romei, F Gemignani, S Landi, R Ciampi, A Tacito, E Molinaro, L Agate, V Bottici,[...]. Endocr Relat Cancer 2011
44
18

Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.
K M Carlson, S Dou, D Chi, N Scavarda, K Toshima, C E Jackson, S A Wells, P J Goodfellow, H Donis-Keller. Proc Natl Acad Sci U S A 1994
510
8

Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
Andreas Machens, Henning Dralle. J Clin Endocrinol Metab 2010
125
8

RET revisited: expanding the oncogenic portfolio.
Lois M Mulligan. Nat Rev Cancer 2014
248
8

Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations.
Rebecca L Margraf, David K Crockett, Patti M F Krautscheid, Ryan Seamons, Fernanda R O Calderon, Carl T Wittwer, Rong Mao. Hum Mutat 2009
91
8

Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study.
Frederic Castinetti, Xiao-Ping Qi, Martin K Walz, Ana Luiza Maia, Gabriela Sansó, Mariola Peczkowska, Kornelia Hasse-Lazar, Thera P Links, Sarka Dvorakova, Rodrigo A Toledo,[...]. Lancet Oncol 2014
72
11

Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective.
Michael Brauckhoff, Andreas Machens, Kerstin Lorenz, Trine Bjøro, Jan Erik Varhaug, Henning Dralle. Ann Surg 2014
44
18

Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
Cristina Romei, Alessia Tacito, Eleonora Molinaro, Laura Agate, Valeria Bottici, David Viola, Antonio Matrone, Agnese Biagini, Francesca Casella, Raffaele Ciampi,[...]. Clin Endocrinol (Oxf) 2015
29
27

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
Jacques Barbet, Loïc Campion, Françoise Kraeber-Bodéré, Jean-François Chatal. J Clin Endocrinol Metab 2005
204
8

Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.
Reese W Randle, Courtney J Balentine, Glen E Leverson, Jeffrey A Havlena, Rebecca S Sippel, David F Schneider, Susan C Pitt. Surgery 2017
58
13

Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).
Rajesh V Thakker, Paul J Newey, Gerard V Walls, John Bilezikian, Henning Dralle, Peter R Ebeling, Shlomo Melmed, Akihiro Sakurai, Francesco Tonelli, Maria Luisa Brandi. J Clin Endocrinol Metab 2012
550
8

Medullary thyroid microcarcinoma: a population-level analysis of 310 patients.
Hadiza S Kazaure, Sanziana A Roman, Julie A Sosa. Cancer 2012
43
16


Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine.
E Modigliani, R Cohen, J M Campos, B Conte-Devolx, B Maes, A Boneu, M Schlumberger, J C Bigorgne, P Dumontier, L Leclerc,[...]. Clin Endocrinol (Oxf) 1998
327
7

Distribution of RET Mutations in Multiple Endocrine Neoplasia 2 in Denmark 1994-2014: A Nationwide Study.
Jes Sloth Mathiesen, Jens Peter Kroustrup, Peter Vestergaard, Kirstine Stochholm, Per Løgstrup Poulsen, Åse Krogh Rasmussen, Ulla Feldt-Rasmussen, Mette Gaustadnes, Torben Falck Ørntoft, Thomas van Overeem Hansen,[...]. Thyroid 2017
21
33

Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.
C Eng, D P Smith, L M Mulligan, M A Nagai, C S Healey, M A Ponder, E Gardner, G F Scheumann, C E Jackson, A Tunnacliffe. Hum Mol Genet 1994
431
7

Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness.
Rachel K Voss, Lei Feng, Jeffrey E Lee, Nancy D Perrier, Paul H Graham, Samuel M Hyde, Frances Nieves-Munoz, Maria E Cabanillas, Steven G Waguespack, Gilbert J Cote,[...]. J Clin Endocrinol Metab 2017
28
25

Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium.
Andreas Machens, Kerstin Lorenz, Carsten Sekulla, Wolfgang Höppner, Karin Frank-Raue, Friedhelm Raue, Henning Dralle. Eur J Endocrinol 2013
51
13

Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.
C Eng, L M Mulligan, D P Smith, C S Healey, A Frilling, F Raue, H P Neumann, M A Ponder, B A Ponder. Clin Endocrinol (Oxf) 1995
122
7

RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
Rossella Elisei, Cristina Romei, Barbara Cosci, Laura Agate, Valeria Bottici, Eleonora Molinaro, Mariangela Sculli, Paolo Miccoli, Fulvio Basolo, Lucia Grasso,[...]. J Clin Endocrinol Metab 2007
127
7

2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer.
R Elisei, M Alevizaki, B Conte-Devolx, K Frank-Raue, V Leite, G R Williams. Eur Thyroid J 2013
48
14

Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.
Jes Sloth Mathiesen, Mouhammed Amir Habra, John Howard Duncan Bassett, Sirazum Mubin Choudhury, Sabapathy Prakash Balasubramanian, Trevor A Howlett, Bruce G Robinson, Anne-Paule Gimenez-Roqueplo, Frederic Castinetti, Peter Vestergaard,[...]. J Clin Endocrinol Metab 2017
18
38

Genotype-specific progression of hereditary medullary thyroid cancer.
Andreas Machens, Kerstin Lorenz, Frank Weber, Henning Dralle. Hum Mutat 2018
16
43

Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study.
Frederic Castinetti, Steven G Waguespack, Andreas Machens, Shinya Uchino, Kornelia Hasse-Lazar, Gabriella Sanso, Tobias Else, Sarka Dvorakova, Xiao Ping Qi, Rossella Elisei,[...]. Lancet Diabetes Endocrinol 2019
28
25


Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
David S Cooper, Gerard M Doherty, Bryan R Haugen, Richard T Kloos, Stephanie L Lee, Susan J Mandel, Ernest L Mazzaferri, Bryan McIver, Furio Pacini, Martin Schlumberger,[...]. Thyroid 2009
6


Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC.
Karin Frank-Raue, Susanne Rondot, Friedhelm Raue. Mol Cell Endocrinol 2010
61
9

RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China.
Xiao-Ping Qi, Xiao-Ling Chen, Ju-Ming Ma, Zhen-Fang Du, Jun Fei, Chang-Ping Yang, Jun Cheng, Qi-Zhe Song, Jian-Shan Han, Hang-Yang Jin,[...]. Thyroid 2012
22
27

Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level.
Andreas Machens, Ulrich Schneyer, Hans-Jürgen Holzhausen, Henning Dralle. J Clin Endocrinol Metab 2005
165
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.